Despite the rise of a vaccine skeptic in the campaign of US presidential election winner Donald Trump, GSK CEO Emma Walmsley ...

Walmsley said Mackay has "played a very significant role to help deliver the reshaping of GSK and to improve our operating and financial performance," and welcomed the new CFO, highlighting Brown ...

GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to ...

But Sky News reports that shareholders want the incoming CEO to have a reduced pay package compared with her predecessor. Previously head of GSK’s consumer ... at pace with new scientific ...

The investor, who declined to be identified, pointed to Astra’s steadier flow of new products. Philip Hampton, GSK’s chairman ...

Curevac N.V. ( (CVAC) ) has released its Q3 earnings. Here is a breakdown of the information Curevac N.V. presented to its investors. CureVac ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

Quarterly sales of GSK's RSV vaccine dropped more than 70%, following narrower recommendations for who should get the shot.

In collaboration with GlaxoSmithKline (NYSE ... As CureVac N.V. (NASDAQ:CVAC) welcomes Axel Sven Malkomes as its new CFO, investors might be curious about the company's financial health and ...

In collaboration with GlaxoSmithKline (NYSE:GSK), CureVac reported encouraging ... As CureVac N.V. (NASDAQ:CVAC) welcomes Axel Sven Malkomes as its new CFO, investors might be curious about the ...